DINESH

PI Industries

Latest CMP 2,490
Today's Change ▼ -0.17%
52-Week High / Low 3,876 | 2,483
Price Date: 14-Aug-2026
Recommendation Sell
Target Price 2,635
Expected Upside 2.9%
Forecast Horizon 2 Years
Historical CAGR 18.9%
1,000 Invested 17-Aug-2006
Today's Value 31,685
Investment Period 20 Years

Stock Snapshot

Post Results Return
-8.5%
Mild Negative Re-rating
1-Year Target Price
2,355
2-Year Target Price
2,635
52-Week High / Low
3,876 / 2,483
20-Day Return
-6.0%
Market Cap (Cr.)
37,850
Current PE
32.1
P/BV Ratio
3.3
Dividend Yield
0.4%
Industry PE
16.2

Price Performance

Basis of our Recommendation

PI Industries is currently navigating a challenging global agrochemical environment, characterized by weak demand and pricing pressures that have impacted near-term margins. Management's strategic pivot towards high-growth segments, particularly biologicals and pharma CRDMO, is crucial for diversifying revenue streams and stabilizing performance. The company's robust $1.2 billion order book and a healthy pipeline of over 60 projects provide a solid foundation for future growth, despite cyclical export headwinds and gestation costs in new business verticals. Vista's financial outlook anticipates accelerating revenue growth, supported by the company's focus on innovation and new product launches, although margins are expected to remain under pressure. The ongoing geopolitical tensions are contributing to rising chemical prices, enhancing pricing power within the industry, which could benefit PI Industries in the long run. Over the next 12-24 months, key opportunities include the commercialization of new molecules and scaling the peptide-based biological platform, while watchpoints include the off-patent status of primary molecules and potential volatility in global supply chains

👍 Why We Like This Stock

  • Management's focus on diversifying into high-growth segments like biologicals and pharma CRDMO is expected to stabilize revenue streams
  • A strong order book of $1.2 billion and a pipeline of over 60 projects provide a solid foundation for future growth
  • Improving pricing power in the industry due to geopolitical tensions may enhance revenue potential

Things To Watch Out For

  • Near-term margins are under pressure due to weak demand and competitive pricing in the core CSM segment
  • The off-patent status of key molecules poses risks to revenue stability
  • Cyclical export headwinds and gestation costs in new business verticals may hinder short-term performance

Key Parameters

Balance Sheet Strength
Conservatively Financed
Market Share
Stable
Industry Outlook
Improving
Analyst View
Buy
Dividend History
Consistent
FII Holdings
Reducing

Financial Snapshot

Actuals Forecast
FY24 FY25 FY26 FY27 FY28
Revenue (Cr.) 7,666 7,978 6,714 6,672 7,194
Profit Before Tax (Cr.) 1,897 2,145 1,593 1,197 1,485
PBT Margin 24.7% 26.9% 2372.7% 17.9% 20.6%
Net Profit (Cr.) 1,540 1,713 1,270 955 1,184
Earnings Per Share 101.3 112.7 83.6 62.8 77.9

Analyst Recommendations

Broker Recommendation Target Price Date
Axis Securities ▲ Buy 3,045 13-Aug-2026
Citigroup ▼ Sell 2,375 13-Aug-2026
DAM Capital ▼ Sell 2,556 21-May-2026
Deven Choksey ► Add 2,976 22-May-2026
HSBC ► Hold 2,720 13-Aug-2026
Jeffries ▲ Outperform 2,910 13-Aug-2026
Morgan Stanley ▲ Overweight 3,883 21-May-2026
Motilal Oswal ▲ Buy 3,000 13-Aug-2026
Prabhudas Liladhar ► Hold 2,569 13-Aug-2026
Consensus Recommendation ▲ Buy
Consensus Target 2,770
Coverage 9 Analysts
Analysts' Viewpoint
PI Industries is focusing on transforming into an innovation-led technology platform by scaling its biologicals business and advancing its pharma CRDMO platform, which is expected to drive long-term growth. The company maintains a strong competitive position with a $1.2 billion order book and a robust pipeline of projects. However, near-term performance is constrained by global agrochemical headwinds, including pricing pressure and inventory overhang, impacting margins. Future catalysts include the launch of new products and a gradual recovery in export volumes.

Company Overview

Show Company Profile

PI Industries Limited, together with its subsidiaries, manufactures and distributes of agricultural chemicals in India, rest of Asia, North America, Europe, and internationally. It operates through Agro Chemicals and Pharma segments. The company offers agrochemicals, including insecticides, fungicides, herbicides, and biologicals; crop solutions for soybeans, chili, sugarcane, rice, wheat, cotton, and corn, as well as horticulture products; and plant nutrients and specialty chemicals. It also provides research and development services, such as target discovery, molecule design, library synthesis, lead optimization, biological evaluation, and route synthesis. In addition, the company offers custom synthesis and manufacturing solutions, including process research and development, analytical method development, synthesis of reference standards, structure elucidation and synthesis of impurities, physio-chemical studies and 5-batch analysis under GLP conditions, scale-up studies, safety data generation, waste categorization and treatability studies, process/plant engineering, and large-scale commercial production; and distribution services. The company sells its products to farmers, distributors, retailers, and sellers. It also exports its products. PI Industries Limited was incorporated in 1946 and is based in Gurugram, India.